COMPREHENSIVE EPILEPSY PROGRAM
The Adult and Pediatric Epilepsy Program at Wayne State University/Detroit Medical Center provides state of the art medical and surgical treatment for individuals with epilepsy and is a top research program in epilepsy research. The program provides comprehensive epilepsy care through a dedicated multidisciplinary team that includes adult and pediatric specialists including dedicated neurologists/epileptologists, neurosurgeons, neuropsychologists, epilepsy nurse coordinators, neuroradiologists, and EEG technologists. Control of seizures is one treatment goal; optimizing quality of life is a second. The program has been designated as a Level Four Epilepsy Center, the highest category, by the National Association of Epilepsy Centers.
The adult epilepsy program is lead by Director Aashit Shah, MD and supported by doctors: Deepti Zustshi, MD, and Maysaa M. Basha, MD. The adult epilepsy program is well integrated with the pediatric epilepsy program in the Division of Pediatric Neurology, which receives referrals for surgery from national and international sources and extramural research support from multiple NIH grants. Lead by Eishi Asano, MD, PhD, Director of EEG laboratory at Children’s Hospital of Michigan and Sandeep Sood, MD, the pediatric epilepsy neurosurgeon. The faculty members of the Comprehensive Epilepsy Program come from a diverse background and are leaders in their respective fields. They are recognized as the best in their fields by their peers, and Drs Shah, and Sood were named to The Best Doctors in America for 2014-2015, a national listing of physicians who represent the top five percent of doctors in more than 400 specialties and sub-specialtiesof medicine.
A full complement of advanced diagnostic tests, including video-EEG monitoring, high-resolution volumetric MRI scanning, positron emission tomography (PET) scanning with multiple tracers, functional MRI (fMRI), MR spectroscopy (MRS), and other cutting-edge MR imaging modalities utilizing the 3-Tesla unit at WSU, intraoperative EEG monitoring, and neuropsychological evaluation including intracarotid amytal (Wada) testing, is available to establish seizure classification, to assess response to medical therapy, and to evaluate patients for epilepsy surgery.
Participation in investigational, multicenter trials of new antiepileptic medications is also available for patients with difficult to control epilepsy. When the medical management fails, the comprehensive epilepsy program evaluation may recommend epilepsy surgery. In that case, a team of subspecialty trained neurosurgeons provide state of the art surgical care.